Elaine Siegfried
Dermatology · Saint Louis, MONPI 1508975160
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Sanofi at 45.4% of the total. Reporting peaked in 2024 at $202,286 and has fallen 54.7% since, to $91,637 in 2025. Among dermatology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $1986.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$388K
- Regeneron Healthcare Solutions, Inc.$165K
- Sanofi-aventis U.S. LLC$128K
- Regeneron$36K
- Dermavant Sciences, Inc.$28K
- LEO Pharma Inc.$23K
- plus $88K from 16 others
Across 570 payments — averaging $2677.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1.1M
- Amgen$222K
- Sanofi$98K
- Eli Lilly$90K
- Janssen Research & Development, LLC$11K
- Novartis$9K
- plus $11K from 2 others
What the payments were for
- Consulting fees$411,32248%
- Speaking & faculty fees$345,30340%
- Travel & lodging$90,80111%
- Food & beverage$8,5191%
- Education$1470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 125 | $388,423 |
| Regeneron Healthcare Solutions, Inc. | 149 | $165,053 |
| Sanofi-aventis U.S. LLC | 23 | $128,401 |
| Regeneron | 24 | $35,696 |
| Dermavant Sciences, Inc. | 21 | $27,525 |
| LEO Pharma Inc. | 12 | $22,626 |
| Pfizer | 16 | $18,746 |
| AbbVie | 12 | $17,967 |
| UCB SA | 11 | $16,709 |
| Novartis | 4 | $6,652 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $5,276 |
| Eli Lilly | 1 | $4,800 |
| Arcutis Biotherapeutics, Inc. | 13 | $4,169 |
| Verrica Pharmaceuticals Inc. | 3 | $3,812 |
| LNHC, Inc | 5 | $3,324 |
| Incyte Corporation | 1 | $2,950 |
| UCB Biosciences Inc. | 2 | $2,760 |
| Nobelpharma America, LLC | 3 | $537 |
| Gilead | 1 | $410 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $145 |
| Chiesi USA, Inc. | 1 | $96 |
| Krystal Biotech Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$856,092 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Other dermatology in Saint Louis
- Brian KimSaint Louis$861K
- Craig LeonardiSaint Louis$569K
- Mary GeorgeSaint Louis$400K
- Duane DilworthSaint Louis$288K
- Jeffrey ReedSaint Louis$170K
- Emily ColeSaint Louis$163K
- Dee GlaserSaint Louis$131K
- Milan AnadkatSaint Louis$129K
- Jason AmatoSaint Louis$45K
- Amy MusiekSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.